NIA Small Business Awards for Alzheimer's Research & Care Innovations
"The National Institute on Aging (NIA) Small Business Awards program supports research on Alzheimer's disease and related dementias to advance therapies, devices, tools, and care practices. Funding opportunities, application types, and active grants are detailed, encouraging breakthroughs in prevention, diagnosis, treatment, and caregiving."
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
National Institute on Aging Small Business Awards to Advance Research on Alzheimer s Disease and Alzheimer s Related Dementias Lorenzo Refolo & M-D Kerns National Institute on Aging
The NIA SBA Program aims to support the discovery, development and commercialization of new therapies, novel devices, analytical tools, health care programs and practices that will improve prevention and treatment, as well as caregiving for patients with AD/ADRD.
Broadly speaking the NIA SBA Program will support research that address the following topics: Prevention Diagnosis Treatment Care Analytical Tools
Application Types Application Types Phase I- feasibility and proof-of-concept Phase II-continue R&D initiated in Phase I - funding is based on results achieved in Phase I + scientific and merit and commercial potential of the project proposed in Phase II Fast Track- 1 application for Phase I and Phase II that is submitted and reviewed together Phase IIB Competing Renewal- for projects that require additional funding beyond the original Phase II award. These applications require competitive peer review. Direct to Phase II- for Phase II R&D for projects that have demonstrated the scientific and technical merit, feasibility and proof of concept technical
Currently Active SBIR & STTR Funding Opportunities PA-16-032/Parent SBIR [R43/R44] 1. Application Types Allowed -new Phase I, new Fast Track, Phase II renewal, Phase IIB-competing renewal 2. Application Due Dates -Sept 5, Jan 5, April 5 3. Expiration Date -April 6, 2017 4. Award Budget -statutory guidelines -$150K (Phase 1), $1.0M (Phase II) -for specific topics and with appropriate justification ->$225K (Phase I) , >$1.5M (Phase II) ***Applicants are strongly encouraged to contact NIH program officials prior to submitting any application in excess of the guidelines
PAR-14-088 Direct Phase II SBIR [R44] 1. Application Types Allowed - new Direct Phase II 2. Application Due Dates - Sept 5, Jan 5, April 5 3. Expiration Date - January 8, 2017 4. Award Budget - statutory guidelines :$1.0M - for specific topics and with appropriate justification $2.0M/ 3yrs
PA-16-303/ Parent STTR[R41/R42] 1. Application Types Allowed - new Phase I, new Fast Track, Phase II renewal, Phase IIB-competing renewal 2. Application Due Dates - Sept 5, Jan 5, April 5 3. Expiration Date - April 6, 2017 4. Award Budget - statutory guidelines -$150K (Phase 1), $1.0M (Phase II) - for specific topics and with appropriate justification ->$225K (Phase I) , >$1.5M (Phase II) ***Applicants are strongly encouraged to contact NIH program officials prior to submitting any application in excess of the guidelines
Coming Soon Coming Soon Advancing Research on Alzheimer's Disease and Alzheimer's-related Dementias (ADRD) (R43/R44) - $15M set aside for 2017 Advancing Research on Alzheimer's Disease and Alzheimer's-related Dementias (ADRD) (R41/R42) - $5M set aside for 2017
NIA SBC Opportunities for AD Translational Research Funding Discovery/Preclinical Development STTR/SBIR Drug Discovery for Nervous System Disorders Alzheimer sDrug Development Program NIH Hits to Leads Lead Candidate Selection Assay IND-enabling studies Target ID Screening Phase I IND Development Optimization Assay Development and Screening Chemical Probe Development Blueprint Neurotherapeutics Program Clinical Development AD Pilot Ph1/Ph2 AD Ph3 Phase I Phase II Phase III SBIR
Other Funding Opportunities Open to SBCs Other Funding Opportunities Open to SBCs PAR 14-284: HTS to Discovery Chemical Probes (R01) PAR 14-279: Discovery of in vivo Chemical Probes PAR 14-292: Blueprint Neurotherapeutics Network :Small Molecule Drug Discovery for Disorders of the Nervous System (UH2/UH3) PAR 15-174: Alzheimer s Drug Development Program (U01) PAR 16-041: Drug Discovery for Nervous System Disorders PAR 16-365: Pilot Clinical Trials for the Spectrum of Alzheimer s Disease and Age-related Cognitive Decline (R01) PAR-16-364: Phase III Clinical Trials for the Spectrum of Alzheimer s Disease and Age-related Cognitive Decline (R01)
Program Contacts Dr. Lorenzo Refolo Email: RefoloL@nia.nih.gov Dr. Michael-David A.R.R. Kerns Email: Michael-David.Kerns@nih.gov
